AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
We would love to hear your thoughts on the episodes!
Dr Paul Ridker discusses his paper on residual inflammatory risk that was recently published in the Lancet with Dr. Thomas Nero. He discusses the pathology of inflammation as part of atherosclerosis, utilization of hs-CRP in clinical trials and in daily practice as well as current therapeutic options and ongoing investigations.